Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

ARCHIVES : 309 forms

Sorting of results :

I-NORM - Management by French General Practitioners of uncontrolled hypertensive patients treated by dual therapy

Head : Herrmann Marie-Annick, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Version 1
Voir
View
Overview

91

Last update : 01/01/2018

ARCHIVE

I-NORM - Management by French General Practitioners of uncontrolled hypertensive patients treated by dual therapy

Head : Herrmann Marie-Annick, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Main objective

Describe medical strategies used by general practitioners for uncontrolled hypertension despite dual-therapy: the I-NORM survey

Inclusion criteria

Register: Patient>=18 years, seen in routine consultation, monitored for HBP, known for more than 3 months, treated via fixed or free dual therapy for his HBP, dual therapy initiated by the participating doctor or the corresponding specialist.
Study: pt from the register, uncontrolled HBP (SBP >=140 mmhg and /or DBP>=90mmhg all comer pt or SBP >=130 mmhg and /or DBP>=80mmhg diabetic pt or with kidney failure), not participating into a clinical trial

Last update : 01/01/2018

Voir
View

MANIF-2000 FOLLOWED BY MANIF-2 - Cohort of HIV-Seropositive Individuals Infected by Use of Intravenous drugs: Prospective Study in Marseille, Avignon, Nice and Ile-de-France

Head : Carrieri Maria-Patrizia, ORS PACA - INSERM U912
Obadia Yolande, ORS PACA

Version 3
Voir
View
Overview

92

Last update : 09/05/2017

ARCHIVE

MANIF-2000 FOLLOWED BY MANIF-2 - Cohort of HIV-Seropositive Individuals Infected by Use of Intravenous drugs: Prospective Study in Marseille, Avignon, Nice and Ile-de-France

Head : Carrieri Maria-Patrizia, ORS PACA - INSERM U912
Obadia Yolande, ORS PACA

Main objective

General objective: MANIF 2000 is a cohort of HIV-1 seropositive patients that have been infected through intravenous drug use. Patients should have an initial CD4 count of > 300/mm3. The initial aim of this study was to compare HIV progression according to whether patients were still active addicts, substituting or sober. This goal was revised in light of the changes in HIV history with the release of highly active combination therapy and the treatment of addicts with buprenorphine substitution. MANIF 2000 has become an observational cohort study focused on risk-related sexual behaviours associated with drug addiction, as well as adherence to therapy and interaction between substitution and treatment. Secondary objectives: - To determine the impact of depression and HIV treatment adherence on clinical progression; - to determine the impact of retention in substitution treatment on virological success.

Inclusion criteria

HIV-1 or HIV-2 seropositive patients that have been infected through intravenous drug use with an initial CD4 count greater than 300/mm3 and at clinical stage A or B.

Last update : 09/05/2017

Voir
View

ADHOC - Observational study on the various arrangements for caring for patients with type-2 diabetes treated by associating oral diabetes medication and insulin

Head : VIGNAL Franck, Sanofi Aventis

Version 1
Voir
View
Overview

93

Last update : 01/01/2018

ARCHIVE

ADHOC - Observational study on the various arrangements for caring for patients with type-2 diabetes treated by associating oral diabetes medication and insulin

Head : VIGNAL Franck, Sanofi Aventis

Main objective

Describe the various arrangements for caring for patients with type-2 diabetes treated by associating oral diabetes medication and insulin as well as their repercussion on HbA1c

Inclusion criteria

man or woman, over the age of 18 years, having type-2 diabetes treated by the association
of oral diabetes medication and insulin for at least 6 months, accepting to participate in the study

Last update : 01/01/2018

Voir
View

PREFACE - Study on the prevalence of facial lipoatrophy in patients infected by HIV virus receiving antiretroviral drugs - FRAN08-005

Head : Cohen-Codar Isabelle

Version 3
Voir
View
Overview

94

Last update : 07/01/2019

ARCHIVE

PREFACE - Study on the prevalence of facial lipoatrophy in patients infected by HIV virus receiving antiretroviral drugs - FRAN08-005

Head : Cohen-Codar Isabelle

Main objective

Describe the prevalence of the facial lipoatrophy in patients infected by HIV virus and receiving antiretroviral drugs. Describe the prevalence of lipoatrophies and lipodystrophic mixed syndromes.
Evaluate the score of quality of life, using the patients multi-dimensional auto-questionnaire and specific ABCD "Assessment of Body Change and Distress".

Inclusion criteria

Patient infected by HIV virus, receiving antiretroviral drugs for at least 1 month and coming to consultation at his usual follow-up center, during the period of the study, obtaining of the written consent for the collect and exploitation of his personal data.

Last update : 07/01/2019

Voir
View

Young-Thyr - Risk Factors of Differentiated Thyroid Cancer in Young Patients in Eastern France: A Case-Control Study

Head : De Vathaire Florent, Equipe 3 Épidémiologie des cancers : radiocarcinogenèse et effets iatrogènes des traitements UMR 1018 Center for research in epidemiology and population health (CESP)

Version 1
Voir
View
Overview

95

Last update : 01/01/2020

ARCHIVE

Young-Thyr - Risk Factors of Differentiated Thyroid Cancer in Young Patients in Eastern France: A Case-Control Study

Head : De Vathaire Florent, Equipe 3 Épidémiologie des cancers : radiocarcinogenèse et effets iatrogènes des traitements UMR 1018 Center for research in epidemiology and population health (CESP)

Main objective

To highlight genetic and environmental factors that contribute to the onset of differentiated thyroid cancer in children and young adults. To study the potential consequences of the Chernobyl accident.

Inclusion criteria

- Men or women - residing in Eastern France

Last update : 01/01/2020

Voir
View

Flurec - Recurring influenza virus infections and implications in terms of epidemic recurrences and pandemic risk.

Head : Carrat Fabrice, UMR-S 707 / Epidémiologie des maladies infectieuses et modélisation
De Lamballerie Xavier, UMR-D 190, Emergence des pathologies virales

Version 1
Voir
View
Overview

96

Last update : 01/01/2020

ARCHIVE

Flurec - Recurring influenza virus infections and implications in terms of epidemic recurrences and pandemic risk.

Head : Carrat Fabrice, UMR-S 707 / Epidémiologie des maladies infectieuses et modélisation
De Lamballerie Xavier, UMR-D 190, Emergence des pathologies virales

Main objective

To explore cross-protective immunity involving different A/H1N1 viruses (seasonal and pandemic) and the seasonal A/H3N2 virus through data gathered from this study. This study also aims to identify the epidemiological, immunological and virological factors that determine the risk of recurring influenza infections as well as characterise the population's herd immunity and its evolution.

Inclusion criteria

The "influenza" group comprises of patients enrolled after general medical consultation for influenza-like illness during seasonal epidemic. The "non-influenza" group comprises of patients enrolled after general medical consultation during seasonal epidemic for a reason other than influenza, yet that was acute in nature e.g. infectious diarrhoea, minor trauma.

Last update : 01/01/2020

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here